These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12762202)

  • 21. Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy.
    Davies JE; Rose C; Sarkar S; Rubinsztein DC
    Sci Transl Med; 2010 Jun; 2(34):34ra40. PubMed ID: 20519718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [From gene to disease; the PABN1 gene and oculopharyngeal muscular dystrophy].
    Schreuder AH; de Die-Smulders CE; Herbergs J; Koehler PJ
    Ned Tijdschr Geneeskd; 2006 May; 150(20):1124-6. PubMed ID: 16756225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oculopharyngeal muscular dystrophy (OPMD) and dementia in a 75-year-old female.
    Nisbet MK; Marshall L
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31537606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oculopharyngodistal myopathy is a distinct entity: clinical and genetic features of 47 patients.
    Durmus H; Laval SH; Deymeer F; Parman Y; Kiyan E; Gokyigiti M; Ertekin C; Ercan I; Solakoglu S; Karcagi V; Straub V; Bushby K; Lochmüller H; Serdaroglu-Oflazer P
    Neurology; 2011 Jan; 76(3):227-35. PubMed ID: 21242490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of impairments in oculopharyngeal muscular dystrophy.
    Brisson JD; Gagnon C; Brais B; Côté I; Mathieu J
    Muscle Nerve; 2020 Aug; 62(2):201-207. PubMed ID: 32270505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene].
    Pou Serradell A; Lloreta Trull J; Corominas Torres JM; Hammouda EH; Urtizberea JA; Richard P; Brais B
    Neurologia; 2004 Jun; 19(5):239-47. PubMed ID: 15150706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. My, what asthenia you have.
    Lee MS; Kosmorsky GS; Cook JR; Barton JJ; Briemberg HR
    Surv Ophthalmol; 2008; 53(5):506-11. PubMed ID: 18929761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between physical symptoms and health-related quality of life in oculopharyngeal muscular dystrophy.
    Youssof S
    Muscle Nerve; 2016 May; 53(5):694-9. PubMed ID: 26453481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of a Taiwanese family with oculopharyngeal muscular dystrophy.
    Kuo HC; Chen CM; Lee-Chen GJ; Hu FJ; Chu CC; Liou CW; Huang CC
    J Neurol Sci; 2009 Mar; 278(1-2):21-4. PubMed ID: 19101703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oculopharyngeal muscular dystrophy revelated by dysphagia].
    Escudié L; Payen JL; Thiry-Escudié I; Carreiro M; Trémelet L; Seigneuric C
    Rev Med Interne; 2005 Sep; 26(9):759-62. PubMed ID: 16023269
    [No Abstract]   [Full Text] [Related]  

  • 31. Familial arachnoid cysts associated with oculopharyngeal muscular dystrophy.
    Jadeja KJ; Grewal RP
    J Clin Neurosci; 2003 Jan; 10(1):125-7. PubMed ID: 12464544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Surgery for blepharoptosis in muscular dystrophy].
    Mahler O; Milstein A; Pollack A; Hauben D
    Harefuah; 2000 Dec; 139(11-12):434-7, 494. PubMed ID: 11341188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of rare recessive oculopharyngeal muscular dystrophy (OPMD) coexisting with hereditary neuropathy with liability to pressure palsies (HNPP).
    Marsh EA; Robinson DO
    Clin Neurol Neurosurg; 2008 May; 110(5):525-8. PubMed ID: 18358598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oculopharyngeal muscular dystrophy: phenotypic and genotypic studies in a Chinese population.
    Shan J; Chen B; Lin P; Li D; Luo Y; Ji K; Zheng J; Yuan Y; Yan C
    Neuromolecular Med; 2014 Dec; 16(4):782-6. PubMed ID: 25283883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hip flexion weakness is associated with impaired mobility in oculopharyngeal muscular dystrophy: a retrospective study with implications for trial design.
    Youssof S; Schrader R; Bear D; Morrison L
    Neuromuscul Disord; 2015 Mar; 25(3):238-46. PubMed ID: 25500011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eyelid ptosis (Blepharoptosis) for the primary care practitioner.
    Avdagic E; Phelps PO
    Dis Mon; 2020 Oct; 66(10):101040. PubMed ID: 32605719
    [No Abstract]   [Full Text] [Related]  

  • 37. Unique PABPN1 gene mutation in a large Bulgarian family with OPMD.
    Mihaylova V; Müller T; Petrova I; Tournev I; Cherninkova S; Walter MC; Deschauer M
    J Neurol; 2008 Apr; 255(4):609-11. PubMed ID: 18274805
    [No Abstract]   [Full Text] [Related]  

  • 38. Cognitive impairment and reduced life span of oculopharyngeal muscular dystrophy homozygotes.
    Blumen SC; Bouchard JP; Brais B; Carasso RL; Paleacu D; Drory VE; Chantal S; Blumen N; Braverman I
    Neurology; 2009 Aug; 73(8):596-601. PubMed ID: 19704078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features of myasthenia gravis.
    Hopkins LC
    Neurol Clin; 1994 May; 12(2):243-61. PubMed ID: 8041340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent Onset of Bilateral Ptosis.
    Feinstein E; Chen J; Setabutr P
    JAMA Ophthalmol; 2017 Apr; 135(4):397-398. PubMed ID: 28114672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.